CODX logo

CODX
Co-Diagnostics Inc

32,143
Mkt Cap
$17.76M
Volume
2.86M
52W High
$1.55
52W Low
$0.2275
PE Ratio
-0.26
CODX Fundamentals
Price
$0.2461
Prev Close
$0.2701
Open
$0.2701
50D MA
$0.3877
Beta
1.47
Avg. Volume
2.63M
EPS (Annual)
-$1.24
P/B
0.30
Rev/Employee
$5,833.70
Loading...
Loading...
News
all
press releases
Co-Diagnostics to Present on Co-Dx PCR Platform and AI Integration at Point-of-Care Testing 2025
Co-Diagnostics to Present on Co-Dx PCR Platform and AI Integration at Point-of-Care Testing 2025 Co-Diagnostics to Present on Co-Dx PCR Platform and AI Integration at Point-of-Care Testing 2025 PR...
PR Newswire·8d ago
News Placeholder
More News
News Placeholder
Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India
Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India PR Newswire SALT LAKE CITY, Dec. 9, 2025 Ongoing...
PR Newswire·9d ago
News Placeholder
CoDiagnostics (CODX) Upgraded to Buy: Here's What You Should Know
CoDiagnostics (CODX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·15d ago
News Placeholder
Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health
Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and...
PR Newswire·27d ago
News Placeholder
Co-Diagnostics, Inc. (CODX) Reports Q3 Loss, Misses Revenue Estimates
CoDiagnostics (CODX) delivered earnings and revenue surprises of +15.79% and -51.67%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Co-Diagnostics Reports Third Quarter 2025 Financial Results
Co-Diagnostics Reports Third Quarter 2025 Financial Results Co-Diagnostics Reports Third Quarter 2025 Financial Results PR Newswire SALT LAKE CITY, Nov. 13, 2025 SALT LAKE CITY, Nov. 13, 2025...
PR Newswire·1mo ago
News Placeholder
Ardent Health, Inc. (ARDT) Surpasses Q3 Earnings and Revenue Estimates
Ardent Health, Inc. (ARDT) delivered earnings and revenue surprises of +23.81% and +1.55%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
What to Expect from Co-Diagnostics's Earnings
read more...
Benzinga·1mo ago
News Placeholder
Utah Governor Cox and BioUtah Recognize Co-Diagnostics Following Recent JV Announcement in Kingdom of Saudi Arabia
Utah Governor Cox and BioUtah Recognize Co-Diagnostics Following Recent JV Announcement in Kingdom of Saudi Arabia Utah Governor Cox and BioUtah Recognize Co-Diagnostics Following Recent JV...
PR Newswire·1mo ago
News Placeholder
Organon (OGN) Q3 Earnings and Revenues Beat Estimates
Organon (OGN) delivered earnings and revenue surprises of +8.60% and +2.02%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
<
1
2
...
>

Latest CODX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.